Asthma News

SAN ANTONIO — Corticosteroid use for asthma exacerbations increased during the delta and omicron waves of the COVID-19 pandemic, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — Seventy percent of patients with severe eosinophilic asthma on mepolizumab for 5 to 6 years had no exacerbations for 1 year, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — Researchers validated the Pediatric Asthma Risk Score, a tool that predicts early-life asthma, across several diverse cohorts of children aged 5 to 10 years, according to study results.

The U.S. Environmental Protection Agency, or EPA, is now seeking comments on its proposal to change its National Ambient Air Quality Standards for annual fine particulate matter from 12 µg/m3 to a level between 9 µg/m3 and 10 µg/m3.

Adults with asthma experienced more exacerbations and acute respiratory infections after COVID-19 restrictions were relaxed, according to study results published in Thorax.

Adults who were taking dupilumab for their atopic dermatitis also experienced significant improvements in their mild asthma, primarily in the first 16 weeks, according to a study published in Clinical and Translational Allergy.

In patients with severe, uncontrolled asthma, tezepelumab reduced the rate of asthma exacerbations and was tolerated for up to 2 years, according to an extension study published in The Lancet Respiratory Medicine.

The prevalence of asthma rose slightly among teens and youth from some race/ethnicity groups in states with recreational cannabis laws compared with states where cannabis is illegal, according to a study published in Preventive Medicine.

Defined as three or more canisters a year, overuse of short-acting beta 2 agonists was associated with increased risk for exacerbations among children with asthma, according to a study published in Pediatric Allergy and Immunology.

Genetic variants related to GERD heightened risks for both asthma and atopic dermatitis by 21%, according to study results published in American Journal of Respiratory and Critical Care Medicine.